Dyssomnias
15
1
2
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
6.7%
1 terminated out of 15 trials
88.9%
+2.4% vs benchmark
40%
6 trials in Phase 3/4
50%
4 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (15)
Multifaceted Benefits of Auricular Point Sticking for IVF Patients: Psychological Well-being, Sleep, and Treatment Outcomes
Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms
Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)
A Multicomponent Intervention for Prevention and Treatment of Sleep Disturbances in a Psychiatric Intensive Care Unit
Online Cognitive Behavior Therapy for Comorbid Sleep Problems in Alcohol Use Disorder
Twenty-six Week Extension Trial of Org 50081 (Esmirtazapine) in Outpatients With Chronic Primary Insomnia (176003/P05721/MK-8265-007)
A Long-Term Safety Study of Org 50081 (Esmirtazapine) in Elderly Outpatients With Chronic Primary Insomnia (176005/P05697/MK-8265-001)
Efficacy and Safety Study of Org 50081 (Esmirtazapine) in Elderly Participants (P05709)
A 6-Month Efficacy and Safety Study of Org 50081 in Adult Patients With Chronic Primary Insomnia (21106/P05701/MK-8265-002)
iCBT for Adolescents With Co-morbid Insomnia
Sleep Application Diary and Sleep Hygiene in Adolescents
Melatonin Treatment After Laparoscopic Cholecystectomy
Sleep Disturbance and Bipolar Disorder
Intensive Care Unit (ICU) Sleep Quality and Neurocognitive Performance
Study of Melatonin: Sleep Problems in Alzheimer's Disease